Conclusion: NADH supplementation is safe and has a low incidence of side effects. Future investigations are needed to evidence the clinical benefits regarding specific diseases and doses administered.
PubMed 37971292 ↗Nadh
The short answer. There isn't much data on Nadh yet — 45 mentions, 9 with a clear outcome — so treat these numbers as anecdotal. It is most often used for energy: 100% of 15 reports say that improved. It is well studied — 27 meta-analyses on PubMed.
From 45 mentions in total — the rest didn't say how it went and aren't counted.
What Nadh does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 27 meta-analyses on PubMed ↗ · 32 randomized trials ↗
Conclusion: We also provide an excursus on the relative contribution of cardiomyocytes, fibroblasts, endothelial and smooth muscle cells to the pathophysiology of heart failure in diabetes. After having described the preclinical tools currently available to dissect the mechanisms of this complex disease, we conclude with a section on the most recent updates of the literature on clinical management.
PubMed 34627874 ↗Conclusion: Conclusions: Though some DSs showed potential in reducing fatigue in ME/CFS, methodological limitations and inconsistent results hinder definitive conclusions. Future research should improve diagnostic criteria and include more diverse populations.
PubMed 39940333 ↗Conclusion: The pooled results showed that there was a significant association between mtDNA T4216C variation and MS (OR = 1.38, 95 % CI = 1.13-1.67, P = 0.001). The present systematic review and meta-analysis suggest that mtDNA T4216C variation is a contributory factor in susceptibility to MS.
PubMed 27457485 ↗267 human trials on ClinicalTrials.gov test Nadh — 129 completed, 46 recruiting now. See all on ClinicalTrials.gov ↗
- Unravelling the Effects of Nicotinamide/Pyrroloquinolone Quinone /Citicoline/Homotaurine Fixed Combination on Contrast Sensitivity, Quality of Life, and Reading Performance in Glaucoma · Glaucoma · 2026
- Comparison of Three Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels · NAD, NAD+ Levels in the Blood · 2026
- Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels · NAD+ Levels in the Blood · 2024
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Their NADH is crazy effective. Cleanest, most natural-feeling energy I've ever felt.”
“For me nadh, resveratrol and shilajit (sometimes with coq10) is my unbeatable energy stack.”
“tried NADH? different from all the NAD+ stuff everyone pushes here, actually worked for my post-covid fog”
“I have been getting good results from methylfolate, vit c, NADH (sublingual), ornithine 400mg paired with coffee in the morning”
Top discussions (5)
- covid brain fog 2 years later still fucked, what even works anymore ↗
- Always Tired ↗
- Is there any interest in a supplements experience day? ↗
- Insight on caffeine and how it works. ↗
- There's a community of us that have ADHD-I, disassociation & major depressive disorder but everything disappears during a hangover. ↗
Other options for energy
Sources
- User reports: 45 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate